2024-08-03 2025-08-31 true No description of principal activity Acting Office - Tax and Accounts 1.0 15873421 bus:FullAccounts 2024-08-03 2025-08-31 15873421 bus:Micro-entities 2024-08-03 2025-08-31 15873421 bus:AuditExempt-NoAccountantsReport 2024-08-03 2025-08-31 15873421 bus:SmallCompaniesRegimeForAccounts 2024-08-03 2025-08-31 15873421 bus:PrivateLimitedCompanyLtd 2024-08-03 2025-08-31 15873421 2024-08-03 2025-08-31 15873421 2025-08-31 15873421 bus:RegisteredOffice 2024-08-03 2025-08-31 15873421 core:WithinOneYear 2025-08-31 15873421 core:AfterOneYear 2025-08-31 15873421 2023-08-03 15873421 bus:Director1 2024-08-03 2025-08-31 15873421 bus:Director1 2025-08-31 15873421 bus:CompanySecretary1 2024-08-03 2025-08-31 15873421 bus:LeadAgentIfApplicable 2024-08-03 2025-08-31 15873421 2024-08-02 15873421 core:CostValuation core:Non-currentFinancialInstruments 2025-08-31 15873421 core:CostValuation core:Non-currentFinancialInstruments 2024-08-02 15873421 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-08-31 15873421 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 15873421 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 15873421 core:ShareProfitOrLossIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 15873421 core:ProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-08-31 15873421 core:ImpairmentReversalProvisionsForImpairmentInvestments core:Non-currentFinancialInstruments 2025-08-31 15873421 core:ForeignExchangeDifferencesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 15873421 core:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 15873421 core:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-08-31 15873421 core:Non-currentFinancialInstruments 2025-08-31 15873421 core:Non-currentFinancialInstruments 2024-08-02 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 15873421
England and Wales

 

 

 


Dormant Accounts

for the period ended 31 August 2025

for

JCPHARMA LTD

 
 
 
£
2025
£
Current assets 1 
Net current assets/(liabilities) 1 
Total assets less current liabilities 1 
Net assets/(liabilities) 1 
 
Capital and reserves 1 
 
For the period ended 31 August 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's Responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476 of the Companies Act 2006.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Signed on behalf of the board of directors:


---------------------------------------------
Jessica Stephanie Rose Corrigan
Director

Date approved: 28 April 2026
1